A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Recruiting · NCT06447597 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 / Phase 3 | 2026-08-14 | NCT06447597 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Jiaolian Drug Research and Development Co., Ltd | 6 |
| Shanghai Pharmaceuticals Holding Co., Ltd | 20 |
18 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.